The Latin America, Middle East and Africa Bioinformatics Market should witness market growth of 17.8% CAGR during the forecast period (2022-2028).
A thorough understanding of the molecules that comprise a cell, tissue, or organism is provided through omics technology. They are largely focused on the non-targeted, non-biased detection of all genes (genomics), mRNA (transcriptomics), proteins (proteomics), and metabolites (metabolomics) in a particular biological sample. The combination of these methodologies is known as system biology, and this might also be referred to as advanced biology.
Experiments in systems biology and omics are distinct from conventional investigations, which are mostly hypothesis-driven. While no hypothesis is specified or mandated in systems biology studies, all data are collected and evaluated to produce a hypothesis that may be tested further. These experiments use holistic methodologies instead. Omics technology may be used to better understand not just physiological processes that occur naturally but also those that occur in illness, where it can be used for prognostication, diagnosis, and screening. It can also be used to better understand the genesis of diseases.
Rising R&D spending in transcriptomic technologies by pharmaceutical and biotechnology companies, as well as increased demand for tailored medication in cancer treatment, are driving the growth of the RNA analysis/transcriptomics market. Additionally, Oxford Brookes University recognized the development of improved single-cell transcriptomic technologies in April 2021.
The International Cancer Genomic Consortium (ICGC) was established to provide funding for extensive genome analyses of 50 distinct kinds and subtypes of malignant cancer. It enables the epigenomic, genomic, and transcriptome analysis of even more than 25, 000 cancer genomes. Although cancer transcriptomics is being given attention, the African continent still lags behind wealthy nations in terms of implementation.
The Brazil market dominated the LAMEA Bioinformatics Market by Country in 2021; thereby, achieving a market value of $356 Million by 2028. The Argentina market is exhibiting a CAGR of 18.5% during (2022-2028). Additionally, The UAE market would experience a CAGR of 17.5% during (2022-2028).
Based on Product & Services, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services. Based on Sector, the market is segmented into Medical Biotechnology, Plant Biotechnology, Environmental Biotechnology, Animal Biotechnology, Forensic Biotechnology and Others. Based on Application, the market is segmented into Genomics, Chemoinformatics & Drug Design, Transcriptomics, Metabolomics, Proteomics and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Qiagen N.V., Agilent Technologies, Inc., Illumina, Inc., Waters Corporation, PerkinElmer Inc., Genedata AG, Neogenomics laboratories, BGI Group
A thorough understanding of the molecules that comprise a cell, tissue, or organism is provided through omics technology. They are largely focused on the non-targeted, non-biased detection of all genes (genomics), mRNA (transcriptomics), proteins (proteomics), and metabolites (metabolomics) in a particular biological sample. The combination of these methodologies is known as system biology, and this might also be referred to as advanced biology.
Experiments in systems biology and omics are distinct from conventional investigations, which are mostly hypothesis-driven. While no hypothesis is specified or mandated in systems biology studies, all data are collected and evaluated to produce a hypothesis that may be tested further. These experiments use holistic methodologies instead. Omics technology may be used to better understand not just physiological processes that occur naturally but also those that occur in illness, where it can be used for prognostication, diagnosis, and screening. It can also be used to better understand the genesis of diseases.
Rising R&D spending in transcriptomic technologies by pharmaceutical and biotechnology companies, as well as increased demand for tailored medication in cancer treatment, are driving the growth of the RNA analysis/transcriptomics market. Additionally, Oxford Brookes University recognized the development of improved single-cell transcriptomic technologies in April 2021.
The International Cancer Genomic Consortium (ICGC) was established to provide funding for extensive genome analyses of 50 distinct kinds and subtypes of malignant cancer. It enables the epigenomic, genomic, and transcriptome analysis of even more than 25, 000 cancer genomes. Although cancer transcriptomics is being given attention, the African continent still lags behind wealthy nations in terms of implementation.
The Brazil market dominated the LAMEA Bioinformatics Market by Country in 2021; thereby, achieving a market value of $356 Million by 2028. The Argentina market is exhibiting a CAGR of 18.5% during (2022-2028). Additionally, The UAE market would experience a CAGR of 17.5% during (2022-2028).
Based on Product & Services, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services. Based on Sector, the market is segmented into Medical Biotechnology, Plant Biotechnology, Environmental Biotechnology, Animal Biotechnology, Forensic Biotechnology and Others. Based on Application, the market is segmented into Genomics, Chemoinformatics & Drug Design, Transcriptomics, Metabolomics, Proteomics and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Qiagen N.V., Agilent Technologies, Inc., Illumina, Inc., Waters Corporation, PerkinElmer Inc., Genedata AG, Neogenomics laboratories, BGI Group
Scope of the Study
By Product & Services
- Knowledge Management Tools
- Bioinformatics Platforms
- Bioinformatics Services
By Sector
- Medical Biotechnology
- Plant Biotechnology
- Environmental Biotechnology
- Animal Biotechnology
- Forensic Biotechnology
- Others
By Application
- Genomics
- Chemoinformatics & Drug Design
- Transcriptomics
- Metabolomics
- Proteomics
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific SE
- Qiagen N.V.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Waters Corporation
- PerkinElmer Inc.
- Genedata AG
- Neogenomics laboratories
- BGI Group
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Bioinformatics Market, by Product & Services
1.4.2 LAMEA Bioinformatics Market, by Sector
1.4.3 LAMEA Bioinformatics Market, by Application
1.4.4 LAMEA Bioinformatics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Jun - 2022, Oct) Leading Players
Chapter 4. LAMEA Bioinformatics Market by Product & Services
4.1 LAMEA Knowledge Management Tools Market by Country
4.2 LAMEA Bioinformatics Platforms Market by Country
4.3 LAMEA Bioinformatics Services Market by Country
Chapter 5. LAMEA Bioinformatics Market by Sector
5.1 LAMEA Medical Biotechnology Market by Country
5.2 LAMEA Plant Biotechnology Market by Country
5.3 LAMEA Environmental Biotechnology Market by Country
5.4 LAMEA Animal Biotechnology Market by Country
5.5 LAMEA Forensic Biotechnology Market by Country
5.6 LAMEA Others Market by Country
Chapter 6. LAMEA Bioinformatics Market by Application
6.1 LAMEA Genomics Market by Country
6.2 LAMEA Chemoinformatics & Drug Design Market by Country
6.3 LAMEA Transcriptomics Market by Country
6.4 LAMEA Metabolomics Market by Country
6.5 LAMEA Proteomics Market by Country
6.6 LAMEA Others Market by Country
Chapter 7. LAMEA Bioinformatics Market by Country
7.1 Brazil Bioinformatics Market
7.1.1 Brazil Bioinformatics Market by Product & Services
7.1.2 Brazil Bioinformatics Market by Sector
7.1.3 Brazil Bioinformatics Market by Application
7.2 Argentina Bioinformatics Market
7.2.1 Argentina Bioinformatics Market by Product & Services
7.2.2 Argentina Bioinformatics Market by Sector
7.2.3 Argentina Bioinformatics Market by Application
7.3 UAE Bioinformatics Market
7.3.1 UAE Bioinformatics Market by Product & Services
7.3.2 UAE Bioinformatics Market by Sector
7.3.3 UAE Bioinformatics Market by Application
7.4 Saudi Arabia Bioinformatics Market
7.4.1 Saudi Arabia Bioinformatics Market by Product & Services
7.4.2 Saudi Arabia Bioinformatics Market by Sector
7.4.3 Saudi Arabia Bioinformatics Market by Application
7.5 South Africa Bioinformatics Market
7.5.1 South Africa Bioinformatics Market by Product & Services
7.5.2 South Africa Bioinformatics Market by Sector
7.5.3 South Africa Bioinformatics Market by Application
7.6 Nigeria Bioinformatics Market
7.6.1 Nigeria Bioinformatics Market by Product & Services
7.6.2 Nigeria Bioinformatics Market by Sector
7.6.3 Nigeria Bioinformatics Market by Application
7.7 Rest of LAMEA Bioinformatics Market
7.7.1 Rest of LAMEA Bioinformatics Market by Product & Services
7.7.2 Rest of LAMEA Bioinformatics Market by Sector
7.7.3 Rest of LAMEA Bioinformatics Market by Application
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.2 Eurofins Scientific SE
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Recent strategies and developments:
8.2.4.1 Acquisition and Mergers:
8.3 Qiagen N.V.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.4 Agilent Technologies, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Illumina, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.6 PerkinElmer, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.7 Waters Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Neogenomics, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 BGI Group
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. Genedata AG
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific SE
- Qiagen N.V.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Waters Corporation
- PerkinElmer Inc.
- Genedata AG
- Neogenomics laboratories
- BGI Group
Methodology
LOADING...
